Abstract

Dr. Himani Purohit*, Dr. Omprakash Sharma and Dr. Pratibha

ABSTRACT

Terminalia arjuna, is the botanical name of arjuna, belongs to the family of Combretaceae. Its bark decoction is used for angina pain, hypertension, congestive heart failure, and dyslipidemia, based on the observations described in sncient samhitas. we will study the utility of arjuna in various cardiovascular diseases. Systematic reviews, meta-analyses, and clinical studies of arjuna were retrieved through the use of, Google Scholar, and Cochrane databases. Most of the studies, both experimental and clinical, have suggested that the drug possesses anti-ischemic, antioxidant, hypolipidemic, and antiatherogenic activities.. The drug has shown promising effect on ischemic cardiomyopathy. So far, no serious side effects have been reported with arjuna therapy. Its useful phytoconstituents are: Triterpenoids, ?-sitosterol, flavonoids, and glycosides. Triterpenoids and flavonoids are considered to be responsible for its beneficial antioxidant cardiovascular properties However, its long-term safety still remains to be elucidated. Though there has been seen very fantastic results in angina pectoris, mild hypertension, and dyslipidemia, its exact role in primary/secondary coronary prevention is yet to be explored.